OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reports is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention	65
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes	59
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms	58
Pharmacological properties of baicalin on liver diseases: a narrative review	57
Oral antiviral treatments for COVID-19: opportunities and challenges	47
Recent review of COVID-19 management: diagnosis, treatment and vaccination	46
Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer’s disease	45
In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis	45
Recent progress in biologically active indole hybrids: a mini review	43
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial	42
Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison	39
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury	37
Effects and mechanisms of phthalates’ action on neurological processes and neural health: a literature review	36
A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome	36
Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective	35
Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology	34
Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors	33
Endogenous estrogens—breast cancer and chemoprevention	32
Neuroprotection through G-CSF: recent advances and future viewpoints	30
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression	30
Targeting the CCL2-CCR2 axis in depressive disorders	30
Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease	29
The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells	27
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease	26
Kynurenine pathway in kidney diseases	25